Felix Bennetts is a Research Fellow at the Monash Institute of Pharmaceutical Sciences, Monash University, working under the supervision of Associate Professor David Thal and Dr. Sabatino Ventura. He completed his PhD in October 2024, with a focus on the structural and functional characterisation of the P2X1 receptor. Felix’s current research aims to therapeutically target the P2X1 receptor for the development of non-hormonal, oral male contraceptives. With support from MCI funding, his work contributes to drug discovery efforts focused on identifying potent compounds suitable for future clinical application. In addition to his work on the P2X1 receptor, Felix has a broader interest in membrane proteins, with a focus on using structural biology and pharmacology to identify druggable binding sites and guide the development of small molecule therapeutics.